| Molecular Formula | C16H14N2O2 |
| Molar Mass | 266.29 |
| Melting Point | 116.0 to 120.0 °C |
| Solubility | DMSO: 10 mM |
| Appearance | White solid. |
| Storage Condition | Keep in dark place,Sealed in dry,2-8°C |
| In vitro study | RG13022 suppresses EGF-stimulated cancer cell proliferation. In a cell-free reaction RG13022 inhibits the autophosphorylation reaction of the EGF receptor in immunoprecipitates with an IC 50 of 4 μM. RG13022 inhibits colony formation and DNA synthesis by HER 14 cells, which were stimulated by 50 ng/mL EGF, in a dose-dependent manner. The IC 50 s are 1 and 3 μM for HER 14 colony formation and DNA synthesis, respectively. RG-13022 inhibits not only EGF-induced growth but also growth stimulated by insulin, insulin-like growth factor I, insulin-like growth factor II, or transforming growth factor alpha. RG-13022 also totally blocks estrogen-stimulated phosphorylation of the EGF receptor, as well as estrogen-induced cell proliferation, suggesting that functioning TK pathways are required for estrogen action. |
| In vivo study | RG13022 suppresses tumor growth in nude mice. RG13022 also increases the life span of these tumor-bearing nude mice. |
| Safety Description | S22 - Do not breathe dust. S24/25 - Avoid contact with skin and eyes. |
| WGK Germany | 3 |
| 1mg | 5mg | 10mg | |
|---|---|---|---|
| 1 mM | 3.755 ml | 18.776 ml | 37.552 ml |
| 5 mM | 0.751 ml | 3.755 ml | 7.51 ml |
| 10 mM | 0.376 ml | 1.878 ml | 3.755 ml |
| 5 mM | 0.075 ml | 0.376 ml | 0.751 ml |